Ironwood Pharmaceuticals IRWD Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $26.29M+2,888% | $880K+100% | -$1.03B-689% | $175.07M-66.9% | ||
| $1.88M-6.5% | $2.01M+27.7% | $1.58M+11.1% | $1.42M-6.9% | ||
| $17.25M-42.2% | $29.85M-6.7% | $32.01M+18.3% | $27.05M+21.4% | ||
| —— | $103.55M-43.5% | $183.43M-33.0% | $273.76M+4.5% | ||
| $35K-75.4% | $142K-48.0% | $273K+38.6% | $197K-39.7% | ||
| -$35K+75.4% | -$142K+100.0% | -$1.03B-520,874% | -$197K+39.7% | ||
| $216K+100% | -$106.97M— | —— | -$359.93M-7,811% | ||
| —— | —— | -$565.78M-1,668% | $36.07M-86.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Ironwood Pharmaceuticals generate?
- Ironwood Pharmaceuticals (IRWD) generated $147.2M in operating cash flow over the trailing twelve months.
- Where does Ironwood Pharmaceuticals's cash flow data come from?
- Every line is extracted from Ironwood Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
